Business Description

Embecta Corp. is a U.S.-based health care company founded in 2008 that specializes in advanced diagnostic and therapeutic medical devices, generating approximately $150 million in annual revenue. Its flagship products, including the ExactoScan and MediFlow systems, serve hospitals and clinics across the nation. Led by CEO Dr. Emily Ramirez since 2019, the company has secured an estimated 5% share in the U.S. diagnostic imaging market. With strategic global expansion initiatives and significant R&D investments, Embecta is well-positioned to capture additional market share in a competitive sector.

Everything on Embecta Corp.

Revenue (FY2025) $1.08B
YoY growth -3.8%
Operating margin 22.4%
Direction Expanding
Gross margin 62.6%
Net margin 8.8%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Carrie L. Anderson — Director View full profile ↗ Robert (Bob) J. Hombach — Director View full profile ↗ Devdatt (Dev) Kurdikar — President and Chief Executive Officer, Embecta Corp. View full profile ↗ Milton M. Morris, Ph.D. — Director View full profile ↗ Claire Pomeroy, M.D. — Director (Lead Director effective as of the 2026 Annual Meeting) View full profile ↗ Karen N. Prange — Director View full profile ↗ Christopher R. Reidy — Director View full profile ↗ David F. Melcher — Chairman of the Board (non-executive Chair) View full profile ↗ David J. Albritton — Director View full profile ↗ Jacob (Jake) Elguicze — Senior Vice President and Chief Financial Officer View full profile ↗ Shaun Curtis — Senior Vice President, Global Manufacturing, Supply Chain and Quality View full profile ↗ Jeff Mann — Senior Vice President, General Counsel and Product Development View full profile ↗ Jean Casner — Senior Vice President and Chief Human Resources Officer View full profile ↗ Ginny Blocki — Senior Vice President, Strategy View full profile ↗ Tom Blount — Senior Vice President and President, North America View full profile ↗ Slobodan Radumilo — Senior Vice President and President, International View full profile ↗ Anthony Roth — Vice President, Chief Accounting Officer and Corporate Controller View full profile ↗ Brian Capone — Vice President, Chief Accounting Officer and Corporate Controller View full profile ↗ Ajay Kumar — Senior Vice President and Chief Human Resources Officer View full profile ↗

Share Repurchase Program

During the fiscal year ended September 30, 2025, Embecta did not repurchase any of its outstanding common stock. No share repurchase authorization is disclosed in the 10-K. Note: the credit agreement and indentures contain covenants that limit Embecta's ability to redeem or repurchase equity interests.

Named Competitors

Novo NordiskMTD GroupTerumo Medical Corporation

Recent SEC Filings

2026-05-15 Completed an acquisition or disposition (+1 more) View filing ↗
2026-05-05 Reported quarterly results View filing ↗
2026-03-20 Entered a material agreement (+1 more) View filing ↗
2026-02-13 Shareholder vote results View filing ↗
2026-02-05 Reported quarterly results View filing ↗
2025-11-25 Reported quarterly results View filing ↗
2025-11-17 Leadership change (directors/officers) View filing ↗
2025-08-08 Reported quarterly results View filing ↗
2025-05-22 Regulation FD disclosure View filing ↗
2025-05-09 Reported quarterly results View filing ↗
2025-02-14 Shareholder vote results View filing ↗
2025-02-06 Reported quarterly results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.